EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer

Activating epidermal growth factor receptor (EGFR) mutations are recognized biomarkers for patients with metastatic non-small cell lung cancer (NSCLC) treated with EGFR tyrosine kinase inhibitors (TKIs). EGFR TKIs can also have activity against NSCLC without EGFR mutations, requiring the identificat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Baty, Florent, Rothschild, Sacha, Früh, Martin, Betticher, Daniel, Dröge, Cornelia, Cathomas, Richard, Rauch, Daniel, Gautschi, Oliver, Bubendorf, Lukas, Crowe, Susanne, Zappa, Francesco, Pless, Miklos, Brutsche, Martin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2013
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3769372/
https://ncbi.nlm.nih.gov/pubmed/24039832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0072966
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia